MwanzoEKSO • NASDAQ
add
Ekso Bionics Holdings Inc
Bei iliyotangulia
$ 0.67
Bei za siku
$ 0.66 - $ 0.70
Bei za mwaka
$ 0.66 - $ 3.13
Thamani ya kampuni katika soko
15.02M USD
Wastani wa hisa zilizouzwa
elfu 99.75
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 4.13M | -10.38% |
Matumizi ya uendeshaji wa biashara | 4.85M | -10.01% |
Mapato halisi | -2.07M | 38.42% |
Kiwango cha faida halisi | -50.18 | 31.30% |
Mapato kwa kila hisa | — | — |
EBITDA | -2.23M | 10.97% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 8.29M | -16.55% |
Jumla ya mali | 29.21M | -6.33% |
Jumla ya dhima | 14.34M | -9.96% |
Jumla ya hisa | 14.87M | — |
hisa zilizosalia | 22.00M | — |
Uwiano wa bei na thamani | 0.99 | — |
Faida inayotokana na mali | -23.48% | — |
Faida inayotokana mtaji | -33.02% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -2.07M | 38.42% |
Pesa kutokana na shughuli | -2.28M | 32.09% |
Pesa kutokana na uwekezaji | elfu -8.00 | 52.94% |
Pesa kutokana na ufadhili | 4.69M | — |
Mabadiliko halisi ya pesa taslimu | 2.41M | 171.42% |
Mtiririko huru wa pesa | -1.11M | 57.80% |
Kuhusu
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2005
Makao Makuu
Tovuti
Wafanyakazi
70